Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line

Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G335-42. doi: 10.1152/ajpgi.00167.2005. Epub 2005 Oct 20.

Abstract

Bile reflux has been implicated in the neoplastic progression of Barrett's esophagus (BE). Bile salts increase proliferation in a Barrett's-associated adenocarcinoma cell line (SEG-1 cells) by activating ERK and p38 MAPK pathways. However, it is not clear that these findings in cancer cells are applicable to non-neoplastic cells of benign BE. We examined the effect of bile salts on three human cell lines: normal esophageal squamous (NES) cells, non-neoplastic Barrett's cells (BAR cells), and SEG-1 cells. We hypothesized that bile salt exposure activates proproliferative and antiapoptotic pathways to promote increased growth in BE. NES, BAR, and SEG-1 cells were exposed to glycochenodeoxycholic acid (GCDA) at a neutral pH for 5 min. Proliferation was measured by Coulter counter cell counts and a 5-bromo-2'-deoxyuridine (BrdU) incorporation assay. GCDA-induced MAPK activation was examined by Western blot analysis for phosphorylated ERK and p38. Apoptosis was measured by TdT-mediated dUTP nick-end labeling and annexin V staining after GCDA and UV-B exposure. Statistical significance was determined by ANOVA. NES cells exposed to 5 min of GCDA did not increase cell number. In BAR cells, GCDA exposure increased cell number by 31%, increased phosphorylated p38 and ERK levels by two- to three-fold, increased BrdU incorporation by 30%, and decreased UV-induced apoptosis by 15-20%. In conclusion, in a non-neoplastic Barrett's cell line, GCDA exposure induces proliferation by activation of both ERK and p38 MAPK pathways. These findings suggest a potential mechanism whereby bile reflux may facilitate the neoplastic progression of BE.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenocarcinoma / metabolism
  • Annexin A5 / metabolism
  • Antimetabolites
  • Apoptosis / drug effects
  • Barrett Esophagus / metabolism*
  • Bile Acids and Salts / pharmacology*
  • Blotting, Western
  • Bromodeoxyuridine
  • Cell Count
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Esophageal Neoplasms / metabolism
  • Esophagus / cytology
  • Esophagus / drug effects
  • Esophagus / metabolism
  • Humans
  • In Situ Nick-End Labeling
  • Mitogen-Activated Protein Kinases / metabolism*
  • Phosphorylation
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Annexin A5
  • Antimetabolites
  • Bile Acids and Salts
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Bromodeoxyuridine